| pubmed-article:12209039 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C0027121 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C0443935 | lld:lifeskim |
| pubmed-article:12209039 | lifeskim:mentions | umls-concept:C1515021 | lld:lifeskim |
| pubmed-article:12209039 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:12209039 | pubmed:dateCreated | 2002-9-4 | lld:pubmed |
| pubmed-article:12209039 | pubmed:abstractText | Inflammatory myositides are rare chronic disorders which may be either isolated or associated with other conditions such as connective tissue diseases or neoplasia. A large variety of autoantibodies can be detected in patients with myositis, some of which have a diagnostic and/or a prognostic value. Myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies (anti-U1-snRNP Abs) are usually considered as overlapping syndromes, mainly mixed connective tissue diseases (MCTD) in which muscle symptoms occur insidiously during the disease course and are characterized by a favourable outcome. | lld:pubmed |
| pubmed-article:12209039 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12209039 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12209039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12209039 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12209039 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12209039 | pubmed:issn | 1462-0324 | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:ClauvelJ PJP | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:LacroixCC | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:OksenhendlerE... | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:CoppoPP | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:LassouedKK | lld:pubmed |
| pubmed-article:12209039 | pubmed:author | pubmed-author:BengoufaDD | lld:pubmed |
| pubmed-article:12209039 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12209039 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:12209039 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12209039 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12209039 | pubmed:pagination | 1040-6 | lld:pubmed |
| pubmed-article:12209039 | pubmed:dateRevised | 2007-9-6 | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:meshHeading | pubmed-meshheading:12209039... | lld:pubmed |
| pubmed-article:12209039 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12209039 | pubmed:articleTitle | Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome. | lld:pubmed |
| pubmed-article:12209039 | pubmed:affiliation | Service d'Immuno-Hématologie, Hôpital Saint-Louis, Paris, France. | lld:pubmed |
| pubmed-article:12209039 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12209039 | lld:pubmed |
